Hyperammonemic encephalopathy in an adenocarcinoma patient managed with carglumic acid

about

Acute hyperammonemic encephalopathy after fluoropyrimidine-based chemotherapy: A case series and review of the literature.Oxaliplatin-Induced Hyperammonemic Encephalopathy in a Patient with Metastatic Pancreatic Cancer: A Case Report.

P2860

Q33765436-0BF12014-D0BC-466F-81B5-0A46C02D36E1 Q46251648-678B25A9-7D3C-461A-9683-BB75EC5108BA

P2860

Hyperammonemic encephalopathy in an adenocarcinoma patient managed with carglumic acid

Item

http://www.wikidata.org/entity/Q42036213

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

Hyperammonemic encephalopathy in an adenocarcinoma patient managed with carglumic acid

@en

Hyperammonemic encephalopathy in an adenocarcinoma patient managed with carglumic acid

@nl

type

Item

label

Hyperammonemic encephalopathy in an adenocarcinoma patient managed with carglumic acid

@en

Hyperammonemic encephalopathy in an adenocarcinoma patient managed with carglumic acid

@nl

prefLabel

Hyperammonemic encephalopathy in an adenocarcinoma patient managed with carglumic acid

@en

Hyperammonemic encephalopathy in an adenocarcinoma patient managed with carglumic acid

@nl

P1476

Hyperammonemic encephalopathy in an adenocarcinoma patient managed with carglumic acid

@en

P2093

A A Khan

http://www.w3.org/2001/XMLSchema#string

I Sosova

http://www.w3.org/2001/XMLSchema#string

J Lazier

http://www.w3.org/2001/XMLSchema#string

S M Lupichuk

http://www.w3.org/2001/XMLSchema#string

P2860

Arginine metabolism: boundaries of our knowledge.

Hyperammonemia encephalopathy: an important cause of neurological deterioration following chemotherapy.

New developments in the treatment of hyperammonemia: emerging use of carglumic acid.

Role of carglumic acid in the treatment of acute hyperammonemia due to N-acetylglutamate synthase deficiency

Syndrome of idiopathic hyperammonemia after high-dose chemotherapy: review of nine cases.

The aggravating factors of hyperammonemia related to 5-fluorouracil infusion--a report of two cases.

Hepatic encephalopathy associated with cancer or anticancer therapy.

5-FU-induced hyperammonemic encephalopathy in a case of metastatic rectal adenocarcinoid successfully rechallenged with the fluoropyrimidine analog, capecitabine.

A novel mutation of the ornithine transcarbamylase gene leading to fatal hyperammonemia in a liver transplant recipient.

P304

e736-9

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

case report

P356

10.3747/CO.21.2076

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2014-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

266746740

http://www.w3.org/2001/XMLSchema#string

P698

25302046

http://www.w3.org/2001/XMLSchema#string

P921

adenocarcinoma

P932

4189581

http://www.w3.org/2001/XMLSchema#string

Hyperammonemic encephalopathy in an adenocarcinoma patient managed with carglumic acid

about

P2860

P2860

Hyperammonemic encephalopathy in an adenocarcinoma patient managed with carglumic acid

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P921

P932